Inventor
Bradley M. LUNDE
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,384,851Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use202512,384,847Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen202512,378,318Proteins binding NKG2D, CD16 and a tumor-associated antigen202512,275,791Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use202512,264,200Antibody variable domains targeting the NKG2D receptor202512,215,157Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use202512,129,300Antibody variable domains targeting the NKG2D receptor202411,939,384Antibody variable domains targeting the NKG2D receptor202411,884,732Proteins binding HER2, NKG2D and CD16202411,884,733Antibody variable domains targeting the NKG2D receptor2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2025Patents assigned to DRAGONFLY THERAPEUTICS INC (10)· patent assignee history
2024–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DRAGONFLY THERAPEUTICS INC | 10 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2024–2025 |